Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Thrombosis Research|September 15, 1993
Chelerythrine, a selective protein kinase C inhibitor, counteracts pyrogen-induced expression of tissue factor without effect on thrombomodulin down-regulation in endothelial cellsJ M Herbert, P Savi, M C Laplace, et al.Thrombosis and Haemostasis|October 6, 1998
The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbitJ M Herbert, F Dol, A Bernat, et al.The Journal of Clinical Investigation|April 16, 1998
Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivoJ Herbert, F Bono, J Herault, et al.European Journal of Pharmacology|July 4, 1995
Effect of SR 33805 on arterial smooth muscle cell proliferation and neointima formation following vascular injuryF Dol, P Schaeffer, I Lamarche, et al.European Journal of Pharmacology|January 14, 1994
Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitroJ M Herbert, C Delisée, F Dol, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1996
DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studiesJ M Herbert, A Bernat, F Dol, et al.Journal of Cellular Physiology|February 1, 1997
Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotideJ M Herbert, A F Guy, I Lamarche, et al.Blood|October 1, 1989
Pharmacodynamics and pharmacokinetics of dermatan sulfate in humansF Dol, G Houin, M Rostin, et al.Thrombosis Research|October 15, 1988
Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological propertiesF Dol, C Caranobe, D Dupouy, et al.Thrombosis and Haemostasis|April 8, 1988
Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does notY Cadroy, F Dol, C Caranobe, et al.Pageof 5